Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 22, 2021

SELL
$55.91 - $81.44 $139,775 - $203,600
-2,500 Closed
0 $0
Q4 2020

Feb 03, 2021

BUY
$66.31 - $86.52 $165,775 - $216,300
2,500 New
2,500 $204,000
Q3 2020

Nov 04, 2020

SELL
$68.34 - $85.84 $170,850 - $214,600
-2,500 Closed
0 $0
Q2 2020

Jul 31, 2020

BUY
$49.87 - $98.69 $124,675 - $246,725
2,500 New
2,500 $206,000
Q1 2020

May 08, 2020

SELL
$41.2 - $101.31 $103,000 - $253,275
-2,500 Closed
0 $0
Q4 2019

Feb 21, 2020

BUY
$16.71 - $106.24 $41,775 - $265,600
2,500 New
2,500 $258,000

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.87B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Barber Financial Group, Inc. Portfolio

Follow Barber Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barber Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Barber Financial Group, Inc. with notifications on news.